ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.

Laura C Coates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.